The kynurenine pathway; A new target for treating maternal features of preeclampsia?
Sign Up to like & getrecommendations! Published in 2019 at "Placenta"
DOI: 10.1016/j.placenta.2019.04.007
Abstract: In preeclampsia, vasospasm, oxidative stress, endothelial dysfunction, and immune dysregulation are key mediators of maternal disease. A new time-of-disease treatment is needed with the potential to treat these areas of pathophysiology. A review of the… read more here.
Keywords: treating maternal; pathway new; maternal features; kynurenine pathway ... See more keywords